Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Laurus Labs Ltd.
NSE: LAURUSLABS
|
BSE: 540222
|
ISIN: INE947Q01028
|
Industry: Pharmaceuticals
|
Strong Performer, Getting Expensive
859.7000
-3.45
(
-0.40
%)
NSE
Aug 14, 2025
15:31 PM
101.36% Gain from 52W Low
Volume:
2.9M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Laurus Labs Ltd.
25 Jan 2024
859.70
-0.40%
Operating deleverage drags earnings
Buy:
Laurus Labs Ltd.
by
Motilal Oswal
Target: 440
Motilal Oswal
Number of FII/FPI investors increased from 259 to 293 in Jun 2025 qtr.
More from Laurus Labs Ltd.
Recommended
Five Interesting Stocks Today - August 14, 2025
The Baseline |
14 Aug 2025
Market closes flat, Amara Raja's Q1 net profit drops 20.7% YoY to Rs 194 crore
Trendlyne Marketwatch |
14 Aug 2025
Earnings Call Transcript - Q1FY21 for Laurus Labs
|
31 Jul 2020